Americans Should Pay More Attention to Over-the-Counter (OTC) Medicine Labels According to New Survey

Survey shows women, millennials, African Americans and Hispanics more responsible about OTC use

News provided by

McNeil Consumer Healthcare

15 Oct, 2015, 07:10 ET

FORT WASHINGTON, Pa., Oct. 15, 2015 /PRNewswire-USNewswire/ -- A new survey of more than 2,000 U.S. adults found that while the majority of consumers recognize the importance of reading the label of an OTC medicine when using the medicine for the first time, only 20% re-read the label of an OTC medicine they have used before.

Continue Reading
Every Label, Every Time
Every Label, Every Time

Millions of Americans depend on OTC medicines to deliver relief for minor ailments[1]. While most Americans surveyed report they understand the importance of reading the OTC label, many also report not paying consistent attention to it as a critical tool for the safe and responsible use of OTC medicines. The survey also revealed that 2 out of every 5 consumers consider the directions on the OTC label as just guidelines.

When broken down by age, gender and ethnicity, the survey results point to wide gaps in attitudes over the importance of reading OTC medicine labels. Key findings from the survey include:

  • Women, millennials[2], African Americans and Hispanics tend to be more careful about OTC use.
    • More women find it very important to read an OTC label (81%) and pay attention to restrictions (74%) than men (62% and 58%, respectively).
    • While all age groups find it important to read the label on OTCs they are taking for the first time, significantly more millennials say it is still important to read the label on OTCs they have taken before (82%), whereas only 54% of older Americans over 70 agree.
    • Almost twice as many African-Americans (60%) and Hispanics (57%) say they think it's very important to read the label on an OTC they've taken before, compared to Caucasians (33%).
    • African Americans (72%) and Hispanics (66%) are significantly more likely than Caucasians (58%) to pay attention to active ingredients on the OTC label.

As a result of these findings, McNeil Consumer Healthcare has developed the "Every Label, Every Time" initiative to educate consumers about the appropriate use of OTC medicines, and the importance of reading and following all medicine labels. The website www.everylabeleverytime.com includes key findings from the consumer survey that can be shared via social media, as well as simple but important tips for taking OTC medicines safely. 

"Whether it is the first time or the twentieth time, it is always important to read and follow the label for all medicines, prescription and OTC. As part of our ongoing commitment to promote safe and responsible OTC use, the 'Every Label, Every Time' campaign reinforces the simple tactics for responsible medicine use that we hope every consumer will follow," said Dr. Rajesh Mishra, vice president of Medical and Clinical Affairs at McNeil Consumer Healthcare. "The OTC medicine label contains information consumers need to use a medicine safely and responsibly, in addition to working closely with their healthcare professionals for guidance, and we hope this campaign further educates consumers of the importance of reading the label every time they use their medicine." 

Methodology
From July 13-20, 2015, APCO Insight conducted an online survey among the United States adult population. A total of 2,038 respondents, 1,500 nationally and 538 from the DC metro area, participated in the survey. Responses were broken into representative subgroups and analyzed by OTC usage, gender, age, race/ethnicity, education level, income, US region, and community size. Data have been weighted according to the U.S. census to reflect national representation on key demographic measures. 

About McNeil Consumer Healthcare
McNeil Consumer Healthcare markets a broad range of well-known and trusted over-the-counter (OTC) products. McNeil Consumer Healthcare is most widely recognized for the TYLENOL® brand. Other McNeil Consumer Healthcare brands include BENADRYL®, ZYRTEC® and ZYRTEC® -D allergy medicines; IMODIUM® A-D anti-diarrheal; MOTRIN® IB pain reliever; and SUDAFED® and SUDAFED PE® nasal decongestants.

[1] Consumer Healthcare Products Association. Statistics on OTC Use. Retrieved from http://www.chpa.org/marketstats.aspx
[2] Millennials are defined as adults age 18-34.

Photo: http://photos.prnewswire.com/prnh/20151014/277120-INFO 
Logo: http://photos.prnewswire.com/prnh/20151014/277096LOGO

SOURCE McNeil Consumer Healthcare

PRN Top Stories Newsletters

Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!

Thank you for subscribing!

By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you'll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.
Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.
Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.